Senestech (NASDAQ:SNES) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Senestech (NASDAQ:SNES) released its quarterly earnings data on Tuesday. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02, Zacks reports. The firm had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.63 million. Senestech had a negative return on equity of 78.74% and a negative net margin of 287.39%.

Here are the key takeaways from Senestech’s conference call:

• Direct-to-consumer momentum accelerated, with Q1 DTC revenue up 42% to a record $194,000 and April e-commerce sales up 163% year over year to a record $146,000 after SenesTech took direct control of Amazon and related online operations.
• Subscription revenue is emerging as a key growth driver, rising 44% in Q1 to a record $56,000 and more than doubling subscriber counts; April subscription revenue also jumped 198% year over year, supporting management’s recurring-revenue strategy.
• B2B revenue improved meaningfully, increasing 57% to $298,000 as the company tightened sales processes and focused on larger opportunities across municipal, distributor, professional, and commercial channels.
• Gross margin reached a company record of 68.6%, up from 64.5% a year ago, reflecting better production efficiency and less reliance on discounted sales activity.
• Liquidity remains adequate but profitability is still distant, with $6.8 million of cash providing runway into the third quarter of 2027, while adjusted EBITDA loss remained $1.6 million after approximately $443,000 of one-time restructuring-related expenses.

Senestech Price Performance

Shares of SNES opened at $1.66 on Wednesday. Senestech has a 1-year low of $1.41 and a 1-year high of $6.24. The stock has a market cap of $8.75 million, a PE ratio of -0.60 and a beta of 0.18. The firm has a 50-day simple moving average of $1.74 and a two-hundred day simple moving average of $2.22. The company has a debt-to-equity ratio of 0.02, a current ratio of 12.61 and a quick ratio of 11.36.

Insider Activity

In related news, major shareholder Glenbrook Capital Management acquired 19,725 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were purchased at an average cost of $1.79 per share, for a total transaction of $35,307.75. Following the acquisition, the insider owned 890,635 shares in the company, valued at $1,594,236.65. The trade was a 2.26% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Over the last quarter, insiders have purchased 283,281 shares of company stock valued at $577,607. 2.20% of the stock is currently owned by insiders.

Institutional Trading of Senestech

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jane Street Group LLC acquired a new position in Senestech during the 4th quarter worth $32,000. XTX Topco Ltd acquired a new stake in Senestech in the 4th quarter valued at about $54,000. Geode Capital Management LLC purchased a new position in shares of Senestech in the 2nd quarter valued at about $59,000. Millennium Management LLC purchased a new position in shares of Senestech in the 3rd quarter valued at about $126,000. Finally, DRW Securities LLC grew its position in shares of Senestech by 171.1% during the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after buying an additional 51,818 shares in the last quarter. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Senestech presently has a consensus rating of “Hold”.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.